慢性髓性白血病的动态 慢性髓性白血病的动态
Franziska Michor1, Timothy P Hughes, Yoh Iwasa
1Program for Evolutionary Dynamics, Department of Organismic and Evolutionary Biology, Department of Mathematics, Harvard University, Cambridge, Massachusetts 02138, USA. michor@fas.harvard.edu
伊马替尼有效地减少慢性髓性白血病 (CML) 细胞,但不会消除白血病干细胞. 数学建模揭示了对CML治疗动态和耐药性发展的洞察力.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 数学生物学 数学生物学
背景情况:
- 伊马替尼是慢性髓性白血病 (CML) 的成功向治疗方法.
- 关于伊马替尼能够根除白血病干细胞以及耐药性的动态,仍然存在关键问题.
- 定量聚合酶连锁反应可以准确测量疾病负担.
研究的目的:
- 开发一种数学模型,解释CML中对伊马替尼的分子反应的动力学.
- 为了研究伊马替尼是否能根除白血病干细胞.
- 分析因伊马替尼布耐药性突变而导致复发的动态.
主要方法:
- 一个基于血液形成区分的四个部分的数学模型.
- 对169名患者的数据集进行分析,测量对伊马替尼的分子反应.
- 计算电阻突变概率和电阻检测的时间.
主要成果:
- 该模型准确地解释了imatinib治疗下的白血病细胞的双相指数下降.
- 分化的白血病细胞和原始细胞的循环率分别为0.05/天和0.008/天.
- 伊马替尼抑制分化细胞的产生,但不会耗尽白血病干细胞.
结论:
- 伊马蒂尼布治疗导致差异化CML细胞的显著减少,但节省了白血病干细胞.
- 数学模型提供了对CML治疗动力学和耐药性的定量见解.
- 了解这些动态对于预测复发和开发改进的治疗策略至关重要.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
12:05Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
相关概念视频
Multipotency of Hematopoietic Stem Cells
Regulation of Hematopoietic Stem Cells
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Structure and Function of Leukocytes
White blood cells protect the body...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
